Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac beta-adrenoceptor blockade: the quest for selectivity.

A M Barrett

    Journal De Pharmacologie
    |January 1, 1985
    PubMed
    Summary

    Drug discovery for beta-blockers evolved from early compounds like dichloroisoprenaline to more selective agents. This process highlighted the importance of balancing therapeutic effects with potential adverse reactions for patient safety.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pathological suppression of binocular vision in stroke.

    Optometry and vision science : official publication of the American Academy of Optometry·2026
    Same author

    Acceptable standards for clinic-based digital cognitive assessments: Recommendations from the Global CEO Initiative on Alzheimer's Disease.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
    Same author

    Contralaterally Controlled Functional Electrical Stimulation for Upper Extremity Recovery Following Stroke: A Multisite Randomized Controlled Trial.

    Stroke·2025
    Same author

    Executive functioning and processing speed as predictors of global cognitive decline in Alzheimer's disease.

    Journal of Alzheimer's disease reports·2025
    Same author

    Executive Functioning and Processing Speed as Predictors of Global Cognitive Decline in Alzheimer Disease.

    medRxiv : the preprint server for health sciences·2024
    Same author

    Promoting Growth in Behavioral Neurology: A Path Forward.

    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2024

    Area of Science:

    • Pharmacology
    • Drug Discovery
    • Cardiovascular Medicine

    Background:

    • The development of drugs necessitates a balance between desired pharmacological effects and potential adverse reactions.
    • Beta-adrenoceptor antagonists, crucial in managing cardiovascular and other conditions, have undergone significant evolution in their design and application.
    • Understanding the role of noradrenaline in sympathetic transmission was key to developing these agents.

    Purpose of the Study:

    • To illustrate the drug discovery and development process for beta-adrenoceptor antagonists.
    • To examine the evolution of beta-blocker selectivity and its impact on clinical efficacy and safety.
    • To review the pharmacology of key beta-blockers, including their benefits and drawbacks.

    Main Methods:

    • Historical review of drug discovery and development for beta-adrenoceptor antagonists.
    • Analysis of pharmacological properties, including receptor affinity and intrinsic activity.
    • Clinical observations and adverse event reporting for key compounds.

    Main Results:

    • Early beta-blockers like pronethalol and propranolol showed efficacy but had significant side effects.
    • Practolol introduced cardioselectivity, demonstrating anginal relief via beta-blockade, not local anesthetic activity.
    • Practolol's development highlighted the need to identify properties responsible for unwanted effects, despite its initial acceptance.

    Conclusions:

    • The evolution of beta-blockers demonstrates a progression towards greater selectivity and improved safety profiles.
    • Understanding drug mechanisms and potential side effects is critical for successful therapeutic application.
    • Continued research is essential to refine drug development and minimize adverse events in clinical practice.

    Related Experiment Videos